ABIOMED (ADMD) PT Raised to $145 at Jefferies Following NDR

August 9, 2016 6:47 AM EDT
Get Alerts ABMD Hot Sheet
Price: $109.95 +0.99%

Rating Summary:
    11 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade ABMD Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Jefferies analyst Raj Denhoy reiterated a Buy rating and lifted his price target on ABIOMED (NASDAQ: ABMD) to $145.00 (from $130.00) after hosting management for a series of meetings.

Denhoy commented, "As can be expected for a company that is growing revenue 40%+ and for a stock that has increased 33% this year (after 137% last year), the discussions focused on the sustainability of the company’s growth prospects. The outlook remains very encouraging and we offer some observations below. ABMD remains a top pick."

For an analyst ratings summary and ratings history on ABIOMED click here. For more ratings news on ABIOMED click here.

Shares of ABIOMED closed at $120.26 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment